P.J. Barter

1.2k citations

13 papers · 742 indexed · h-index 9

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 5%
- Lipoproteins and Cardiovascular Health
- Coronary Interventions and Diagnostics
- Cholesterol and Lipid Metabolism

Papers in

Endocrinology, Diabetes and Metabolism 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
Surgery 11
- Lipoproteins and Cardiovascular Health 11
- Coronary Interventions and Diagnostics 2

Co-authors: K.-A. Rye Christie M. Ballantyne Stephen J. Nicholls Steven E. Nissen Rishi Puri Yu Kataoka Kiyoko Uno Raimund Erbel
Journals: Atherosclerosis (2 papers)Journal of the American College of Cardiology (2 papers)Journal of Vascular Surgery (2 papers)Diabetes Care (1 paper)European Heart Journal (1 paper)
Partner nations: Australia United States Germany

In The Last Decade

P.J. Barter

12 papers receiving 723 citations

Peers

Countries citing papers authored by P.J. Barter

Since Specialization

Citations

This map shows the geographic impact of P.J. Barter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.J. Barter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.J. Barter more than expected).

Fields of papers citing papers by P.J. Barter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.J. Barter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.J. Barter. The network helps show where P.J. Barter may publish in the future.

Co-authors

The 25 scholars most cited alongside P.J. Barter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.J. Barter Line = papers co-authored together P.J. Barter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease Journal of Vascular Surgery ·A. Michael Lincoff, Stephen J. Nicholls, Jeffrey Riesmeyer, P.J. Barter, H. Bryan Brewer, bahmadh	2017	4
2	Sex-Related Differences of Coronary Atherosclerosis Regression Following Maximally Intensive Statin Therapy JACC. Cardiovascular imaging ·Rishi Puri, Steven E. Nissen, Mingyuan Shao, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Stephen J. Nicholls	2014	41
3	Variability of LDL-C response with different doses of simvastatin, atorvastatin and rosuvastatin: Results from voyager Atherosclerosis ·B.W. Karlson, M.K. Palmer, Stephen J. Nicholls, Pia Lundman, P.J. Barter	2014	3
4	High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN Diabetes Care ·Brian Stegman, Rishi Puri, Leslie Cho, Mingyuan Shao, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Steven E. Nissen, Stephen J. Nicholls	2014	44
5	Factors underlying regression of coronary atheroma with potent statin therapy European Heart Journal ·Rishi Puri, Steven E. Nissen, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Julie St. John, Kathy Wolski, Kiyoko Uno, Yu Kataoka, Stephen J. Nicholls	2013	59
6	C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy Circulation ·Rishi Puri, Steven E. Nissen, Peter Libby, Mingyuan Shao, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Joel S. Raichlen, Kiyoko Uno, Yu Kataoka, Stephen J. Nicholls	2013	99
7	REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY Journal of the American College of Cardiology ·Stephen J. Nicholls, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, Joel S. Raichlen, Kiyoko Uno, Rishi Puri, Yu Kataoka, Kathy Wolski, Steven E. Nissen	2012	0
8	Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes Journal of the American College of Cardiology ·Sanjay Patel, Brian G. Drew, Shirley Nakhla, Stephen J. Duffy, Andrew Murphy, P.J. Barter, Kerry‐Anne Rye, Jaye Chin‐Dusting, Anh Hoang, Dmitri Sviridov, David S. Celermajer, Bronwyn A. Kingwell	2009	164
9	Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome American Heart Journal ·Gregory G. Schwartz, Anders Olsson, Christie M. Ballantyne, P.J. Barter, Ingar Holme, David Kallend, Lawrence A. Leiter, Eran Leitersdorf, John J.V. McMurray, Prediman K. Shah, Jean‐Claude Tardif, Bernard Chaitman, Jen-Fan Hang, John Mathieson	2009	140
10	Effects of torcetrapib in patients at high risk for coronary events Journal of Vascular Surgery ·P.J. Barter, Mark J. Caulfield, Marie Eriksson	2008	51
11	INTRAVASCULAR ULTRASOUND EVALUATION OF THE EFFECT OF ROSUVASTATIN VERSUS ATORVASTATIN ON PROGRESSION OF CORONARY ATHEROSCLEROSIS: DESIGN OF THE SATURN STUDY Atherosclerosis Supplements ·Stephen J. Nicholls, J.S. Raichlen, Christie M. Ballantyne, P.J. Barter, M. John Chapman, Raimund Erbel, Peter Libby, S.E. Nissen	2008	2
12	The rationale for using apoA‐I as a clinical marker of cardiovascular risk Journal of Internal Medicine ·P.J. Barter, K.-A. Rye	2006	71
13	A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin Atherosclerosis ·Paul Nestel, Leon A. Simons, P.J. Barter, Peter Clifton, David Colquhoun, Ian Hamilton‐Craig, Ken Sikaris, David Sullivan	1997	64

About P.J. Barter

P.J. Barter is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Radiology, Nuclear Medicine and Imaging, Cancer Research and Computational Theory and Mathematics, having authored 13 papers that have together received 742 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (11 papers), Cardiac Imaging and Diagnostics (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cancer, Lipids, and Metabolism (3 papers), Coronary Interventions and Diagnostics (2 papers), Pharmaceutical Economics and Policy (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (300 citations), Surgery (539 citations), Cancer Research (121 citations), Cardiology and Cardiovascular Medicine (167 citations) and Radiology, Nuclear Medicine and Imaging (106 citations). P.J. Barter has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include K.-A. Rye, Christie M. Ballantyne, Stephen J. Nicholls, Steven E. Nissen, Rishi Puri, Yu Kataoka, Kiyoko Uno, Raimund Erbel, Peter Libby and Joel S. Raichlen. Their work appears in journals such as Atherosclerosis, Journal of the American College of Cardiology, Journal of Vascular Surgery, Diabetes Care and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact